| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | President & CEO, Director | Common Stock | 654,683 | $11,679,544 | $17.84 | 09 Dec 2025 | Direct |
| Evommune, Inc. | President & CEO, Director | Employee Stock Option (Right to Buy) | 796,841 | 05 Nov 2025 | Direct | ||
| Evommune, Inc. | President & CEO, Director | Series Seed Preferred Stock | 0 | 07 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | 09 Dec 2025 | 1 | -$501,982 | 4 | President & CEO, Director | 11 Dec 2025, 16:23 |
| EVMN | Evommune, Inc. | 07 Nov 2025 | 2 | $0 | 4 | President & CEO, Director | 12 Nov 2025, 16:22 |
| EVMN | Evommune, Inc. | 05 Nov 2025 | 1 | $0 | 4 | President & CEO, Director | 07 Nov 2025, 16:15 |
| EVMN | Evommune, Inc. | 05 Nov 2025 | 0 | $0 | 3 | President & CEO, Director | 05 Nov 2025, 20:10 |